The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
21 06 2022
Historique:
received: 06 05 2022
revised: 19 06 2022
accepted: 19 06 2022
entrez: 9 7 2022
pubmed: 10 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

The COVID-19 pandemic has been challenging time for medical care, especially in the field of infectious diseases (ID), but it has also provided an opportunity to introduce new solutions in HIV management. Here, we investigated the changes in HIV service provision across Central and Eastern European (CEE) countries before and after the COVID-19 outbreak. The Euroguidelines in Central and Eastern Europe Network Group consists of experts in the field of ID from 24 countries within the CEE region. Between 11 September and 29 September 2021, the group produced an on-line survey, consisting of 32 questions on models of care among HIV clinics before and after the SARS-CoV-2 outbreak. Twenty-three HIV centers from 19 countries (79.2% of all countries invited) participated in the survey. In 69.5% of the countries, there were more than four HIV centers, in three countries there were four centers (21%), and in four countries there was only one HIV center in each country. HIV care was based in ID hospitals plus out-patient clinics (52%), was centralized in big cities (52%), and was publicly financed (96%). Integrated services were available in 21 clinics (91%) with access to specialists other than ID, including psychologists in 71.5% of the centers, psychiatrists in 43%, gynecologists in 47.5%, dermatologists in 52.5%, and social workers in 62% of all clinics. Patient-centered care was provided in 17 centers (74%), allowing consultations and tests to be planned for the same day. Telehealth tools were used in 11 centers (47%) before the COVID-19 pandemic outbreak, and in 18 (78%) after ( As a consequence of the COVID-19 pandemic, tools such as telehealth have become popularized in CEE countries, challenging the traditional approach to HIV care. These implications need to be further evaluated in order to ascertain the best adaptations, especially for HIV medicine.

Identifiants

pubmed: 35805250
pii: ijerph19137595
doi: 10.3390/ijerph19137595
pmc: PMC9265352
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Infect Dis. 2018 May;70:121-130
pubmed: 29550449
Croat Med J. 2021 Dec 31;62(6):542-552
pubmed: 34981686
PLoS One. 2019 Jul 26;14(7):e0220516
pubmed: 31348801
Przegl Epidemiol. 2019;73(1):61-68
pubmed: 31134775
N Engl J Med. 2020 Jun 4;382(23):e82
pubmed: 32240581
Int J Infect Dis. 2020 Jul;96:311-314
pubmed: 32413608
Open Forum Infect Dis. 2021 Jul 01;8(7):ofab283
pubmed: 34307725
J Int AIDS Soc. 2021 Oct;24 Suppl 6:e25810
pubmed: 34713585
AIDS Care. 2004;16 Suppl 1:S43-55
pubmed: 15736821
AIDS. 2021 Jul 1;35(8):1328-1330
pubmed: 33756514
J Med Internet Res. 2019 Jun 17;21(6):e13166
pubmed: 31210136
Int J Environ Res Public Health. 2022 Jan 10;19(2):
pubmed: 35055566
Lancet HIV. 2018 Aug;5(8):e438-e447
pubmed: 30025681
Health Aff (Millwood). 2014 Feb;33(2):194-9
pubmed: 24493760
Clin Infect Dis. 2014 Sep 1;59(5):725-34
pubmed: 24837481
AIDS Patient Care STDS. 2013 Aug;27(8):459-66
pubmed: 23886048
AIDS Patient Care STDS. 2019 Feb;33(2):58-66
pubmed: 30648888
Infect Dis (Lond). 2019 Apr;51(4):277-286
pubmed: 30786803
HIV Med. 2017 May;18(5):370-375
pubmed: 27553526
J Acquir Immune Defic Syndr. 2021 Apr 1;86(4):e114-e115
pubmed: 33346567
AIDS. 2021 Feb 2;35(2):337-341
pubmed: 33165032
Curr Opin HIV AIDS. 2014 Jul;9(4):419-27
pubmed: 24871089
Int J Gen Med. 2021 Apr 29;14:1575-1587
pubmed: 33953605
New Dir Ment Health Serv. 2000 Fall;(87):111-8
pubmed: 11031808
Health Aff (Millwood). 2014 Feb;33(2):258-64
pubmed: 24493769
Br J Ophthalmol. 2018 Nov;102(11):1485-1491
pubmed: 29680803
Int J Environ Res Public Health. 2021 May 11;18(10):
pubmed: 34064970
Clin Infect Dis. 2009 Jan 15;48(2):248-56
pubmed: 19072715
J Parkinsons Dis. 2020;10(3):893-897
pubmed: 32538870
Clin Infect Dis. 2021 Sep 7;73(5):e1222-e1227
pubmed: 34492689

Auteurs

Agata Skrzat-Klapaczyńska (A)

Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warszawa, Poland.

Justyna D Kowalska (JD)

Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warszawa, Poland.

Larisa Afonina (L)

Republic Clinical Hospital for Infections of MoH of the Russian Federation, 101000 Moscow, Russia.

Svitlana Antonyak (S)

Viral Hepatitis and AIDS Department, Gromashevsky Institute of Epidemiology and Infectious Diseases, 01001 Kyiv, Ukraine.

Tatevik Balayan (T)

National Center for Disease Control and Prevention, Yerevan 0002, Armenia.

Josip Begovac (J)

School of Medicine, University Hospital for Infectious Diseases, University of Zagreb, 10000 Zagreb, Croatia.

Dominik Bursa (D)

Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warszawa, Poland.

Gordana Dragovic (G)

Department of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Deniz Gokengin (D)

Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, 35040 Izmir, Turkey.

Arjan Harxhi (A)

Infectious Disease Service, University Hospital Center of Tirana, 1001 Tirana, Albania.

David Jilich (D)

Department of Infectious Diseases, 1st Faculty of Medicine, Charles University in Prague and Faculty Hospital Bulovka Hospital, 18000 Prague, Czech Republic.

Kerstin Kase (K)

West Tallinn Central Hospital, 10111 Tallinn, Estonia.

Botond Lakatos (B)

National Institute of Hematology and Infectious Diseases, South-Pest Central Hospital, National Center of HIV, 1007 Budapest, Hungary.

Mariana Mardarescu (M)

National Institute for Infectious Diseases Matei Bals Bucharest, 021105 Bucharest, Romania.

Raimonda Matulionyte (R)

Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, 08410 Vilnius, Lithuania.

Cristiana Oprea (C)

Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Carol Davila University of Medicine and Pharmacy, 010001 Bucharest, Romania.

Aleksandr Panteleev (A)

City TB Dispensary, 101000 Moscow, Russia.

Antonios Papadopoulos (A)

University General Hospital Attikon, Medical School, National and Kapodistrian University of Athens, 15772 Athens, Greece.

Lubomir Sojak (L)

Department of Infectology and Geographical Medicine, Center for Treatment of HIV/AIDS Patients, Academic L. Derer's University Hospital, 2412 Bratislava, Slovakia.

Janez Tomazic (J)

Clinic for Infectious Diseases, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.

Anna Vassilenko (A)

Global Fund Grant Management Department, Republican Scientific and Practical Center for Medical Technologies, 220004 Minsk, Belarus.

Marta Vasylyev (M)

Astar Medical Center, 79007 Lviv, Ukraine.

Antonija Verhaz (A)

Department for Infectious Diseases, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Republika Srpska, Bosnia and Herzegovina.

Nina Yancheva (N)

Department for AIDS, Specialized Hospital for Active Treatment of Infectious and Parasitic Disease Sofia, 1000 Sofia, Bulgaria.

Oleg Yurin (O)

Central Research Institute of Epidemiology, Federal AIDS Centre, 101000 Moscow, Russia.

Andrzej Horban (A)

Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Medical University of Warsaw, 02-091 Warszawa, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH